The differences across these three areas is what researchers in the study attributed to more changes in the immune cells in the brain of women than in men.
For the study, which was published Nov. 27 in Alzheimer’s & Dementia, researchers analyzed data and brain samples of 469 patients with Alzheimer’s and looked for specific changes in gene expression between males and females.
“At its core, Alzheimer’s disease is a woman’s health issue. To address it, we must understand how biological sex contributes to the underpinnings of this disease,” said study co-author Jessica Caldwell, PhD, director of the Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic. “These findings confirm that we need to look at sex differences in the way the body and brain systems communicate to be able to truly offer women personalized care, and we look forward to continuing this research.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
